Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis

Haik Mkhikian, Ani Grigorian, Carey Li, Chen Hung-Lin, Barbara Newton, Raymond Zhou, Christine Beeton, Sevan Torossian, Grikor Tatarian, Sung-Uk Lee, Ken Lau, Erin Walker, Katherine Siminovitch, K Chandy, Zhaoxia Yu, James Dennis, Michael Demetriou

Research output: Contribution to journalArticlepeer-review

135 Citations (Scopus)
20 Downloads (Pure)


How environmental factors combine with genetic risk at the molecular level to promote complex trait diseases such as multiple sclerosis (MS) is largely unknown. In mice, N-glycan branching by the Golgi enzymes Mgat1 and/or Mgat5 prevents T cell hyperactivity, cytotoxic T-lymphocyte antigen 4 (CTLA-4) endocytosis, spontaneous inflammatory demyelination and neurodegeneration, the latter pathologies characteristic of MS. Here we show that MS risk modulators converge to alter N-glycosylation and/or CTLA-4 surface retention conditional on metabolism and vitamin D3, including genetic variants in interleukin-7 receptor-α (IL7RA*C), interleukin-2 receptor-α (IL2RA*T), MGAT1 (IVAVT−T) and CTLA-4 (Thr17Ala). Downregulation of Mgat1 by IL7RA*C and IL2RA*T is opposed by MGAT1 (IVAVT−T) and vitamin D3, optimizing branching and mitigating MS risk when combined with enhanced CTLA-4 N-glycosylation by CTLA-4 Thr17. Our data suggest a molecular mechanism in MS whereby multiple environmental and genetic inputs lead to dysregulation of a final common pathway, namely N-glycosylation.
Original languageEnglish
Pages (from-to)1-13
Number of pages13
JournalNature Communications
Issue number334
Publication statusPublished - 2011
Externally publishedYes


Dive into the research topics of 'Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis'. Together they form a unique fingerprint.

Cite this